PATRICK STICKLE: Open Payments
NPI 1457021289 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,518 in 70 payments from 14 companies in 2025. Trend: 2023 $1,063 · 2024 $1,190 · 2025 $1,518
Food & beverage: $1,135Education: $383
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 19 | $424 |
| UCB, Inc. | 15 | $219 |
| Lilly USA, LLC | 9 | $169 |
| Eli Lilly and Company | 1 | $99 |
| SANOFI-AVENTIS U.S. LLC | 1 | $99 |
| Regeneron Healthcare Solutions, Inc. | 3 | $78 |
| LEO Pharma Inc. | 4 | $76 |
| ABBVIE INC. | 4 | $69 |
| Novartis Pharmaceuticals Corporation | 3 | $68 |
| GENZYME CORPORATION | 3 | $65 |
Products named: DUPIXENT, ILUMYA, Bimzelx, TALTZ, COSENTYX, CIBINQO, NEMLUVIO, ANZUPGO.
Industry payments across AR — which companies pay providers there.
